News
An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...
3d
Stockhead on MSNFDA Waiting Room: For Aussie applicants, it’s (mainly) business as usual
The US Food & Drug Administration's (FDA) resources have been cut more times than Martin Scorsese’s then-edgy 1988 religious ...
Sadly, in America, you can’t get your hands (or hooves) on it unless you are a quadruped. The Food and Drug Administration ...
9d
Stockhead on MSNHealth Check: Probe steriliser Nanosonics cleans up with second FDA approval
Despite the turmoil afflicting the US Food & Drug Administration (FDA), Australian applicants are not walking away empty ...
Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.
11d
Stockhead on MSNHope grows as cannabis contender enters the Rett syndrome fight
Rett syndrome hits hard and early, but with Neuren’s Daybue and Neurotech’s cannabis-based NTI164 building steam, the fight ...
Dermatologists say that oral minoxidil pills are one of the most effective treatments available for hair loss in women. Why ...
Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...
The rising bladder cancer star that is the combination of Pfizer and Astellas’ Padcev and Merck’s Keytruda is looking to set ...
Jason Bergsbaken, PharmD, MBA, BCOP, highlights the growing role of real-world data in validating or de-implementing therapies, the need for vigilant postapproval outcomes monitoring, and the value of ...
Dr. Rinn: So, the most recent treatment option for obstructive sleep apnea is a newly FDA approved medication called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results